Sign in to view content

BiWeekly Anti-VEGF Dosing for Chronic Refractory Neovascular Age-Related Macular Degeneration Unresponsive to Standard Monthly Dosing

Eric W Schneider, MD

Video
Published 2019

Related

Previous Intravitreal Therapy is Associated With Increased Risk of Posterior Capsule Rupture During Cataract Surgery
Aaron Y Lee, MD, MSCI
Updates from the Field
2016
Brolucizumab: Will it Make a Differance
Andrew P. Schachat, MD
Updates from the Field
2018
The Average Patient Does Not Enter Your Office: What Can We Learn About Treating nAMD From Individual Patient Responses
David S. Boyer, MD
Annual Meeting Talks
2019

Category: AMD-Neovascular

See more